Agenus (AGEN) Earnings Date & Reports

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the bodyâ€™s immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGEN is expected to report earnings to rise 2,269.23% to -307 cents per share on May 09

Q1'24

Est.

$-3.08

Q4'23

Missed

by $0.07

Q3'23

Beat

by $0.04

Q2'23

Est.

$-0.20

Q1'23

Missed

by $0.01

The last earnings report on March 14 showed earnings per share of -12 cents, missing the estimate of -5 cents. With 372.17K shares outstanding, the current market capitalization sits at 43.66M.

View a ticker or compare two or three

Compare

AGEN